Food safety is major concern for both producers and distributors, so it’s no surprise that the global food safety testing space is expected to be worth $8.0 billion by 2021. Lexagene (LXG.V) seeks to take commercial pathogen detection to a whole new level with its groundbreaking tech and company President, Daryl Rebeck, explains the how it works and what it could mean for investors. See for yourself.
Watch live video from EquityDotGuru on www.twitch.tv

FULL DISCLOSURE: Lexagene Holdings is NOT an EQUITY.GURU client.

Written By:

Chris Parry

A multi-Webster Award winner for excellence in BC journalism, Parry is the founder and publisher of Equity.Guru, which he built with the specific plan to blend old school reporting with stock promotion, in a way that puts the emphasis on truth, high standards, and ethics. Parry is a veteran of TV, radio, and print, and consults with public companies to help them figure out their storylines, lay down achievable milestones, and improve their communication with shareholders, while also posting regular deep dive analysis of companies in the public spotlight.

More By This Author
Tags:
Biotech
Livestreams
Parry
Series
biotech
Clean Feed
Lexagene Holdings
livestream
LXG.V
pathogen detection
0 0 votes
Article Rating
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments